Hepatica – new tool informs surgeons about previously undiagnosed background liver disease, helping to improve surgical decision-making in liver cancer care
Oxford December 2nd, 2020. A newly published study on patients with primary and secondary liver cancer shows how Perspectum’s non-invasive MRI technology can…
2 Dec 2020
Post-conference Q&A – AASLD: The Digital Liver Meeting Experience
With AASLD 2020: The Liver Meeting Digital Experience (TLMdX) having come to a close, we spent some time with catch-up Marija Mavar, co-lead of our Pharma Solu…
2 Dec 2020
Perspectum presents new data, addressing key challenges of smart imaging
Dallas, USA, November 26, 2020. New data will be presented by Perspectum at this year’s RSNA meeting. Perspectum will be showcasing AI-powered whole-image…
29 Nov 2020
CHRISTUS Shreveport-Bossier Health System and Perspectum Offer New Insights into Liver Health with LiverMultiScan
CHRISTUS Shreveport-Bossier Health System are pleased to announce a groundbreaking partnership with Perspectum, a leading provider of medical imaging s…
17 Nov 2020
Reversing fatty liver disease; New study in Hong Kong will use state-of-the-art clinical technology to evaluate different weight-loss methods
Reversing fatty liver disease; New study in Hong Kong will use state-of-the-art clinical technology to evaluate different weight-loss methods Singapore Nove…
17 Nov 2020
Perspectum launches new multiorgan imaging offering, Atlas®, for pharma sponsors at The Liver Meeting Digital Experience™ (TLMdX) 2020
Boston, USA, November 10, 2020. Perspectum®, a leading imaging technology company and imaging CRO, elevates their service offering for clinical trials with th…
10 Nov 2020
Perspectum Releases New Whitepaper on The Cost-Effectiveness of Including Imaging in Phase 3 NASH Trials
San Francisco, October 20 2020: Perspectum’s new whitepaper clearly outlines how the upfront cost of pre-screening subjects for NASH clinical trial enrollmen…
20 Oct 2020
Join a Patient Registry
Would you, or someone you care about benefit from a free, state-of-the-art liver test? Perspectum is offering a free LiverMultiScan MRI for individua…
13 Oct 2020
Perspectum’s RADIcAL1 trial – addressing the health economic burden of invasive diagnostics for NAFLD and NASH
Oxford December 9th, 2020. The growing need for cost-effective non-invasive tools to diagnose fatty liver disease and reduce the number of painful, costly and …
9 Oct 2020
New monitoring tool could be a positive change on the horizon for children with autoimmune hepatitis
Oxford October 6th, 2020. State-of-the-art non-invasive multiparametric MRI could offer new possibilities for monitoring and treatment of autoimmune hepatitis …
6 Oct 2020
Perspectum and UK Biobank help to uncover genetic marker associated with fatty liver disease
Oxford September 24th, 2020. The link between a specific genetic marker and severity of non-alcoholic fatty liver disease (NAFLD) has been validated in this st…
24 Sep 2020
New non-invasive MRI biomarker for liver disease could cut costs for drug trials
Oxford September 22nd, 2020. Latest research from Perspectum shows how a new non-invasive combined imaging and blood biomarker could accurately identify NASH i…
22 Sep 2020